Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome

Gemcitabine-induced hemolytic uremic syndrome is an often-missed condition. We present a case outlining the successful management of a patient with metastatic cholangiocarcinoma treated with gemcitabine who subsequently developed hemolytic uremic syndrome. Early recognition and stopping gemcitabine...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2023-03, Vol.15 (3), p.e35874
Hauptverfasser:	Azad, Farhan, Miranda, Clive J, Amin, Al, Hadwani, Ruhi, Gravina, Matthew
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Apheresis Biopsy Blood platelets Cancer therapies Case reports Chemotherapy Cholangiocarcinoma Dehydrogenases Drug dosages Edema Hematology Hepatitis Infections Kidneys Laboratories Liver Metastasis Monoclonal antibodies Oncology Patients Thrombocytopenia Vitamin E
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!